Topical Hemostatic Agents in Gynecologic Surgery for Benign Indications
| Autor: | Anne M. Stachowicz, James L. Whiteside |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Hemostatic Agent
medicine.medical_specialty 030219 obstetrics & reproductive medicine business.industry Administration Topical Operative Time MEDLINE Blood Loss Surgical Obstetrics and Gynecology Fibrin Tissue Adhesive Risk Assessment Hemostatics Gynecologic surgical procedures 03 medical and health sciences 0302 clinical medicine Gynecologic Surgical Procedures Blood loss medicine Operative time Humans Minimally Invasive Surgical Procedures Female 030212 general & internal medicine Intensive care medicine business |
| Zdroj: | Obstetrics and gynecology. 135(2) |
| ISSN: | 1873-233X |
| Popis: | Since a variety of procoagulant products, collectively called hemostatic agents, became available to surgeons in the mid-20th century, their use has increased across multiple specialties, including gynecology. Congruent with past research on the causes of regional variation in the practice of medicine, available evidence suggests that a central predictor for use of these products is physician preference rather than documented clinical necessity. Use of these products adds risks and avoidable cost. This article seeks to highlight specific gynecologic circumstances in which evidence and surgical judgment supports hemostatic agent use and other settings in which use should be reconsidered. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|